Goodwin George 4
4 · Surgery Partners, Inc. · Filed Mar 17, 2022
Insider Transaction Report
Form 4
Goodwin George
President, American Group
Transactions
- Exercise/Conversion
Common Stock
2022-03-15$13.42/sh+33,000$442,860→ 127,429 total - Sale
Common Stock
2022-03-15$50.01/sh−18,786$939,488→ 108,643 total - Sale
Common Stock
2022-03-16$50.88/sh−1,697$86,343→ 106,946 total - Sale
Common Stock
2022-03-15$49.32/sh−7,761$382,773→ 94,429 total - Sale
Common Stock
2022-03-16$52.07/sh−12,500$650,875→ 94,446 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-15$13.42/sh−33,000$442,860→ 115,500 totalExercise: $13.42From: 2021-12-31Exp: 2029-03-15→ Common Stock (33,000 underlying)
Footnotes (3)
- [F1]Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 13, 2022.
- [F2]The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 15, 2022.